Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
RNA (New York, N.Y.)|June 9, 2017
RBM24 promotes U1 snRNP recognition of the mutated 5' splice site in the IKBKAP gene of familial dysautonomiaKenji Ohe, Mayumi Yoshida, Akiko Nakano-Kobayashi, et al.
Scientific Reports|May 31, 2017
Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophyYukiya Sako, Kensuke Ninomiya, Yukiko Okuno, et al.
Molecular and Cellular Biology|June 1, 2004
RB reversibly inhibits DNA replication via two temporally distinct mechanismsSteven P Angus, Christopher N Mayhew, David A Solomon, et al.
Endocrinology|June 13, 2022
High-throughput Screening in Combination With a Cohort Study for Iodothyronine DeiodinasesIchiro Yamauchi, Yoriko Sakane, Yukiko Okuno, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2015
Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomiaMayumi Yoshida, Naoyuki Kataoka, Kenjyo Miyauchi, et al.
Cancer Medicine|February 27, 2025
A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinomaTomohiro Fukui, Kosuke Okasho, Yukiko Okuno, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
Identification of novel N-(morpholine-4-carbonyloxy) amidine compounds as potent inhibitors against hepatitis C virus replicationAkiko Kusano-Kitazume, Naoya Sakamoto, Yukiko Okuno, et al.
Iscience|September 13, 2023
Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPCMotoyasu Hosokawa, Ryuta Mikawa, Atsuko Hagiwara, et al.
Nature Communications|April 23, 2016
Selective inhibition of the kinase DYRK1A by targeting its folding processIsao Kii, Yuto Sumida, Toshiyasu Goto, et al.
Lung Cancer (Amsterdam, Netherlands)|November 30, 2022
A novel cell-based assay for the high-throughput screening of epithelial-mesenchymal transition inhibitors: Identification of approved and investigational drugs that inhibit epithelial-mesenchymal transitionHiroyuki Ishikawa, Toshi Menju, Toshiya Toyazaki, et al.
Pageof 4